دورية أكاديمية
Progress and Discussion of Perioperative Targeted Therapy in Patients with EGFR-mutated Resectable Non-small Cell Lung Cancer
العنوان: | Progress and Discussion of Perioperative Targeted Therapy in Patients with EGFR-mutated Resectable Non-small Cell Lung Cancer |
---|---|
المؤلفون: | Peng SONG, Yong CUI |
المصدر: | Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 383-390 (2024) |
بيانات النشر: | Chinese Anti-Cancer Association; Chinese Antituberculosis Association, 2024. |
سنة النشر: | 2024 |
المجموعة: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
مصطلحات موضوعية: | lung neoplasms, perioperative treatment, neoadjuvant treatment, adjuvant treatment, targeted therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
الوصف: | Lung cancer is still the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) is the main pathological type of lung cancer, accounting for about 80%. Approximately 30% of all patients with NSCLC have resectable early and middle stage disease at the time of diagnosis. Recently, the epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have made a major breakthrough in the adjuvant targeted therapy of EGFR-mutated resectable NSCLC, and are recommended by the guidelines for clinical use. In this review, we summarize the clinical research progress of perioperative adjuvant targeted therapy for EGFR-mutated resectable NSCLC, and discuss the key issues in the clinical researches. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | Chinese |
تدمد: | 1009-3419 1999-6187 |
Relation: | https://doaj.org/toc/1009-3419; https://doaj.org/toc/1999-6187 |
DOI: | 10.3779/j.issn.1009-3419.2024.106.11 |
URL الوصول: | https://doaj.org/article/60cb89985369406083b5edc922a2c1cc |
رقم الأكسشن: | edsdoj.60cb89985369406083b5edc922a2c1cc |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 10093419 19996187 |
---|---|
DOI: | 10.3779/j.issn.1009-3419.2024.106.11 |